NCT00672594View on ClinicalTrials.gov

Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2013

Conditions

Prostate CancerProstatectomy

Interventions

DRUG

Sunitinib Malate

Sunitinib Malate 50mg capsule by mouth once daily for 4 weeks

Trial Locations (2)

27710

Duke University Medical Center, Durham

77030

MD Anderson, University of Texas, Houston

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Duke University

OTHER